Effect of Pramlintide and Liraglutide on Glucagon and Glucose after a Mixed-Meal Tolerance Test in Type 1 Diabetes

被引：0
|
作者：
Galderisi, Alfonso
Patel, Neha S.
Van Name, Michelle A.
Cengiz, Eda
Weinzimer, Stuart A.
Tamborlane, William V.
Sherr, Jennifer L.
机构：
来源：
DIABETES | 2017年 / 66卷
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1132-P
引用
收藏
页码：A302 / A302
页数：1
相关论文
共 50 条
  • [31] GLYCEMIC RESPONSES FOLLOWING A MIXED-MEAL TOLERANCE TEST AMONG CHINESE, MALAY AND ASIAN-INDIANS IN SINGAPORE
    Tan, V.
    Venkataraman, K.
    Tai, E. S.
    Lee, Y. S.
    Leow, M. K. S.
    Khoo, C. M.
    ANNALS OF NUTRITION AND METABOLISM, 2013, 63 : 1214 - 1214
  • [32] A mixed meal tolerance test predicts onset of type 2 diabetes in Southwestern Indigenous adults
    Mitchell, Cassie M.
    Stinson, Emma J.
    Chang, Douglas C.
    Krakoff, Jonathan
    NUTRITION & DIABETES, 2024, 14 (01):
  • [33] Differences in Long-Term Changes in C-peptide Levels after Stimulation With Glucagon or a Mixed-Meal
    Dagan, Shlomo
    Avron, Ann
    Peled, Dana
    Elias, Dana
    Tamir, Merana
    Pozzilli, Paolo
    Raz, Itamar
    Harari, Gil
    Eren, Rachel
    DIABETES, 2013, 62 : A64 - A64
  • [34] Age effect on muscle mitochondrial function and impaired glucose tolerance after a mixed meal
    Short, K
    Bigelow, M
    Nair, K
    DIABETES, 2003, 52 : A346 - A346
  • [35] Comparison effect of hyperglycaemia induced mixed meal tolerance and oral glucose tolerance test on body oxidative stress
    Onalan, Ramazan
    Yildirim, Tekin
    Caniklioglu, Aysen
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2024, 49 (06): : 810 - 817
  • [36] Beta cell function during the oral glucose tolerance test and a mixed meal test in different glucose tolerance groups
    Rijkelijkhuizen, Josina M.
    Mari, Andrea
    Nijpels, Giel
    Rhodes, Thomas
    Kostense, Piet J.
    Heine, Robert J.
    Girman, Cynthia J.
    Dekker, Jacqueline M.
    DIABETES, 2007, 56 : A252 - A252
  • [37] Liraglutide Acutely Suppresses Glucagon, Lipolysis, and Ketogenesis in Type 1 Diabetes
    Garg, Manisha
    Ghanim, Husam
    Kuhadiya, Nitesh D.
    Green, Kelly
    Hejna, Jeanne
    Torre, Barrett
    Dandona, Paresh
    DIABETES, 2017, 66 : A293 - A294
  • [38] Pramlintide reduces the risks associated with glucose variability in type 1 diabetes
    Kovatchev, Boris P.
    Crean, John
    McCall, Anthony
    DIABETES TECHNOLOGY & THERAPEUTICS, 2008, 10 (05) : 391 - 396
  • [39] Liraglutide acutely suppresses glucagon, lipolysis and ketogenesis in type 1 diabetes
    Garg, Manisha
    Ghanim, Husam
    Kuhadiya, Nitesh D.
    Green, Kelly
    Hejna, Jeanne
    Abuaysheh, Sanaa
    Torre, Barrett
    Batra, Manav
    Makdissi, Antoine
    Chaudhuri, Ajay
    Dandona, Paresh
    DIABETES OBESITY & METABOLISM, 2017, 19 (09): : 1306 - 1311
  • [40] PREDICTORS OF THE EFFECTIVENESS OF INCRETIN-BASED THERAPY: RESPONSIVENESS OF C-PEPTIDE TO MIXED MEAL TOLERANCE TEST AND GLUCAGON LOADING TEST IN JAPANESE TYPE 2 DIABETES
    Nara, E.
    Kitamoto, T.
    Matsuzawa, Y.
    Saito, J.
    Omura, M.
    Nishikawa, T.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S23 - S23
12345